Aurobindo Pharma

The company's viral vaccine manufacturing capacity in India would be undertaken in two phases, the first phase would be ready by…

The company’s vaccine candidate has been shortlisted for BIRAC funding, will launch final product by the end of 2022

Reportedly, demurrage charges of approximately Rs 3 crores have been imposed on the pharma sector  

Lupin and Marksans Pharma recall diabetes drugs while Alembic and Aurbindo recall medicines that treat mental disorders

Industry to compile nationwide data of imposed demurrages on each pharma company and present it to government authorities with a…

Recommended measures include alerting medical practitioners about a potential shortage of certain medicines and availability of…

Delay in custom clearance may lead to a shortage of medicines in the global pharma market, caution industry stakeholders

Attorney General Brian E Frosh in a statement issued on Wednesday said the new complaint, filed in the U.S. District Court for the…

The capital market firm raised Aurobindo Pharma's earnings estimates by 5-6 per cent to factor in higher revenue in US &…

Under Paragraph IV Patent Certifications, a company can seek FDA approval to market a generic drug before the expiration of…